87 - Efficacy and Safety of Semaglutide 0.5 mg vs Dulaglutide 1.5 mg Once Weekly in Type 2 Diabetes: Posthoc Analysis of SUSTAIN 7

Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7, SupplementAuthor(s): Ronald Goldenberg, Richard E. Pratley, Vanita R. Aroda, Theis Gondolf, Thomas Hansen, Ildiko Lingvay, Jörg Lüdemann, Trine Vang Skjøth, Adie Viljoen
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research